Evidence map›Paper›PMID 38337975›Full record

ArticlePlants (Basel, Switzerland)2024

Determination of

Abdullah A Shaito, Islam Omairi, Najlaa Al-Thani, Fatiha Seglab, Esraa Ad-Darwish, Firas Kobeissy, Salam Nasreddine

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Plants (Basel, Switzerland) · 2026
    Article
  4. Therapeutic Insights intoPharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Abdullah A ShaitoBiomedical Research Center, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0000-0003-3524-7962
Islam OmairiDepartment of Biological and Chemical Sciences, Faculty of Arts and Sciences, Lebanese International University, Beirut 1105, Lebanon.
Najlaa Al-ThaniResearch and Development Department, Barzan Holdings, Doha P.O. Box 7178, Qatar.ORCID 0000-0002-0659-4992
Fatiha SeglabBiomedical Research Center, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0000-0002-5558-4811
Esraa Ad-DarwishBiotechnology in Forensic Science Program, Faculty of Health Sciences, American University of Science and Technology, Beirut 1100, Lebanon.
Firas KobeissyDepartment of Neurobiology, Center for Neurotrauma, Multiomics & Biomarkers (CNMB), More-House School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA.ORCID 0000-0002-5008-6944
Salam NasreddineBiology Department, Faculty of Sciences-Section I, Group of Anti-Cancer Therapeutic Approaches (ATAC), Laboratory Rammal Rammal, Lebanese University, Beirut 1102, Lebanon.
Lebanese University · LBQatar University · QAAmerican University of Science and Technology · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The anti-lung cancer properties of the plant

Indexed as

A549 cellsantioxidantscisplatinhemolyticherbal medicinelung cancerMedicago orbicularis

Identifiers

PMID38337975
PMCPMC10857225
OpenAlexW4391486460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.